Epidermal-skin-test 1,000 (EST-1,000)--a new reconstructed epidermis for in vitro skin corrosivity testing.

Toxicol In Vitro

Advanced CellSystems GmbH, Mülheimerstr. 26, D-53840 Troisdorf, Germany.

Published: October 2005

The determination of a possible corrosive or irritative potential of certain products and ingredients is necessary for their classification and labeling requirements. Reconstructed skin as a model system provides fundamental advantages to single cell culture testing and leads to promising results as shown by different validation studies (for review: Fentem, J.H., Botham, P.A., 2002. ECVAM's activities in validating alternative tests for skin corrosion and irritation. ATLA 30(Suppl. 2), 61-67). In this study we introduce our new reconstructed epidermis "Epidermal-Skin-Test" (EST-1,000). This fully grown epidermis consists of proliferating as well as differentiating keratinocytes. EST-1,000 shows a high comparability to normal human skin as shown by histological and immunohistochemical data. Characteristic markers (KI-67, CK 1/10/5/14, transglutaminase, collagen IV, involucrin, beta 1 integrin) can be identified easily. The main focus of this work was to characterize EST-1,000 especially with respect to its barrier function by testing several substances of known corrosive potential. Skin corrosion was detected by the cytotoxic effect of the substances on a reconstructed epidermis after short-term application to the stratum corneum. The effect was determined by standard MTT assay and accompanying histological analysis. Hence EST-1,000 shows a very high predictive potential and closes the gap between animal testing and the established full-thickness model Advanced-Skin-Test 2,000 (AST-2,000) (Noll, M., Merkle, M.-L., Kandsberger, M., Matthes, T., Fuchs, H., Graeve, T., 1999. Reconstructed human skin (AST-2,000) as a tool for pharmaco-toxicology. ATLA 27, 302).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2005.06.010DOI Listing

Publication Analysis

Top Keywords

reconstructed epidermis
12
skin corrosion
8
est-1000 high
8
human skin
8
skin
6
reconstructed
5
epidermal-skin-test 1000
4
1000 est-1000--a
4
est-1000--a reconstructed
4
epidermis
4

Similar Publications

Novel Tripeptides as Tyrosinase Inhibitors: In Silico and In Vitro Approaches.

Int J Mol Sci

December 2024

Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Kraków, Poland.

Tyrosinase is a key enzyme responsible for the formation of melanin (a natural skin pigment with ultraviolet-protection properties). However, some people experience melanin overproduction, so new, safe, and biocompatible enzyme inhibitors are sought. New tripeptide tyrosinase inhibitors were developed using molecular modeling.

View Article and Find Full Text PDF

Single-Cell RNA Sequencing Reveals Age-Related Changes in Epidermal Cell Populations and Interactions.

J Invest Dermatol

January 2025

Department of Dermatology Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; A*STAR Skin Research Labs (A*SRL) and Skin Research Institute of Singapore (SRIS), Agency for Science, Technology, and Research (A*STAR), 8A Biomedical Grove, IMMUNOS Building, Biopolis, 138648 Singapore. Electronic address:

View Article and Find Full Text PDF

Downregulation of semaphorin 4A in keratinocytes reflects the features of non-lesional psoriasis.

Elife

December 2024

Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Psoriasis is a multifactorial disorder mediated by IL-17-producing T cells, involving immune cells and skin-constituting cells. Semaphorin 4A (Sema4A), an immune semaphorin, is known to take part in T helper type 1/17 differentiation and activation. However, Sema4A is also crucial for maintaining peripheral tissue homeostasis and its involvement in skin remains unknown.

View Article and Find Full Text PDF

Advances in preparation of acellular human dermis for tissue banking and transplantation.

Cell Tissue Bank

December 2024

NHS Blood and Transplant, Tissue Services R&D, 14 Estuary Banks, Speke, Liverpool, L24 8RB, UK.

Article Synopsis
  • Non-healing wounds lead to significant costs for the NHS, totaling over £5.6 billion annually, prompting the use of skin allografts for better infection protection.
  • A study aimed to validate a new decellularisation method using Benzonase, a single enzyme, to remove DNA from donor skin, which could simplify the process compared to the current dual-enzyme approach.
  • Results showed that both Benzonase and the existing method effectively removed DNA without significant differences in their performance, demonstrating Benzonase's non-toxicity and potential as a cost-effective alternative in wound treatment.
View Article and Find Full Text PDF

Preservation solution protects isolated hair micrografts by inhibiting apoptosis of hair bulb.

Life Sci

January 2025

Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province 510515, China. Electronic address:

Aims: To investigate the effectiveness of histidine-tryptophan-ketoglutarate (HTK) solution compared to Ringer's (RS) solution for preserving isolated hair follicles (HFs), focusing on structural integrity, cell viability, apoptosis prevention, and identifying the mechanisms of cell death during the preservation period.

Materials And Methods: Isolated human HFs were preserved in HTK or RS solution for periods ranging from 2 to 12 h. Morphological changes were assessed using H&E staining and transmission electron microscopy (TEM).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!